Piramidal's AI models were described as still under development and only in research / investigational settings; they are not FDA-cleared or approved and are not intended for clinical decision-making yet.
SourcePublic company, workplace, funding, and market signals
Piramidal is a neuroAI / healthcare AI startup that builds a foundation model for EEG and other brain biosignals, with the first product positioned as an AI copilot for epilepsy diagnosis and real-time ICU EEG monitoring.
Primary product
A foundation model for EEG brainwave data and an AI copilot for epilepsy / real-time EEG interpretation.
Founded
2024
Headquarters
San Francisco, California, United States
Team size
1-10
Industry
Software Development
Sub-industry
NeuroAI / healthcare AI
Offices
0 jobs at Piramidal
Check back later for new openings
Business model
Stage
Seed
Total raised
$8M
Latest round
Seed · Dec 2024
Latest amount
$1.5M
Leadership
Founder & CEO
Co-Founder & CPO
Chief of Staff | Head of BizOps
Investors
Mission-driven and highly technical; the company emphasizes 'AI Symbiosis' and cognitive liberty, explicitly opposing commodification of minds and non-consensual neural manipulation. Hiring signals suggest an engineering-first culture.
Visa sponsorship
Limited
Compensation
Public job postings show Research Engineer pay at $120K-$280K and Front End Engineer pay at $120K-$235K, with YC describing cash around the 60th percentile plus high-percentile equity. One role is limited to US citizens / visa holders.
Benefits
Pricing
Not publicly disclosed.
Differentiators
Technology
Customers
Competitors
Estimated revenue
Less than $1M
Estimated monthly visits
941
Traffic estimate as of Jul 2026
Piramidal's AI models were described as still under development and only in research / investigational settings; they are not FDA-cleared or approved and are not intended for clinical decision-making yet.
SourcePR Newswire · Apr 2026
Announced Piramidal’s first remote monitoring company partner, a real-world pilot, and stated the models are still investigational and not FDA-cleared.
Wired · Aug 2025
Covered the Cleveland Clinic partnership and the use of Piramidal’s model to monitor ICU brain health.
Forbes · Aug 2025
Described Piramidal as a New York-based Y Combinator graduate and said it was collaborating with Cleveland Clinic on an ICU deployment and a commercial product path.
TechCrunch · Aug 2024
Introduced Piramidal's brainwave foundation model, its $6M seed funding, and its goal to improve EEG analysis and neurological diagnosis.
SiliconANGLE · Aug 2024
Reported the $6M seed round led by Y Combinator and highlighted angel participation plus the company’s EEG-analysis focus.